Merck & Co., Inc. (BVMF:MRCK34)

Brazil flag Brazil · Delayed Price · Currency is BRL
56.98
-0.48 (-0.84%)
At close: Aug 26, 2025
-0.84%
Market Cap1.14T
Revenue (ttm)346.63B
Net Income (ttm)89.39B
Shares Outn/a
EPS (ttm)35.34
PE Ratio12.79
Forward PE9.18
Dividend1.56 (2.69%)
Ex-Dividend DateJun 13, 2025
Volume4,526
Average Volume2,798
Open57.45
Previous Close57.46
Day's Range56.89 - 58.07
52-Week Range51.60 - 83.92
Beta0.39
RSI51.13
Earnings DateOct 30, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Brazil Stock Exchange
Ticker Symbol MRCK34
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.